{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tiotropium+%2B+Olodaterol&page=2", "query": { "intervention": "Tiotropium + Olodaterol", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 28, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tiotropium+%2B+Olodaterol&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tiotropium+%2B+Olodaterol&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-01T12:06:01.406Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02085161", "title": "To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "placebo to tiotropium + olodaterol", "type": "DRUG" }, { "name": "tiotropium +olodaterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 304, "start_date": "2014-03", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2017-01-06", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 3, "location_summary": "San Diego, California • Torrance, California • Hartford, Connecticut", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02085161" }, { "nct_id": "NCT01559116", "title": "Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "tiotropium + olodaterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "olodaterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Respimat", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 219, "start_date": "2012-03", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2015-07-16", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 4, "location_summary": "Jasper, Alabama • Easley, South Carolina • Greenville, South Carolina + 1 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Easley", "state": "South Carolina" }, { "city": "Greenville", "state": "South Carolina" }, { "city": "Spartanburg", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01559116" }, { "nct_id": "NCT02296138", "title": "Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "olodaterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 7903, "start_date": "2015-01-13", "completion_date": "2017-03-29", "has_results": true, "last_update_posted_date": "2018-06-04", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 117, "location_summary": "Andalusia, Alabama • Birmingham, Alabama • Florence, Alabama + 100 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Flagstaff", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02296138" }, { "nct_id": "NCT01964352", "title": "Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "tiotropium", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "olodaterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 813, "start_date": "2013-11", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2015-11-25", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 20, "location_summary": "Wheat Ridge, Colorado • Clearwater, Florida • Panama City, Florida + 17 more", "locations": [ { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Panama City", "state": "Florida" }, { "city": "Coeur d'Alene", "state": "Idaho" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01964352" }, { "nct_id": "NCT02799784", "title": "An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI", "type": "DRUG" }, { "name": "TIO/OLO", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 236, "start_date": "2016-07-14", "completion_date": "2017-04-27", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 9, "location_summary": "Clearwater, Florida • Orlando, Florida • St Louis, Missouri + 6 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Medford", "state": "Oregon" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02799784" }, { "nct_id": "NCT03979807", "title": "A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Olodaterol/Tiotropium Bromide", "type": "DRUG" }, { "name": "Umeclidinium/ Vilanterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "40 Years", "sex": "ALL", "summary": "1 Year to 40 Years" }, "enrollment_count": 11296, "start_date": "2019-06-10", "completion_date": "2019-06-11", "has_results": true, "last_update_posted_date": "2021-11-15", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03979807" }, { "nct_id": "NCT02845752", "title": "The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Stiolto Respimat", "type": "DRUG" }, { "name": "Placebo Respimat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "45 Years to 90 Years" }, "enrollment_count": 14, "start_date": "2017-03-01", "completion_date": "2018-08-06", "has_results": true, "last_update_posted_date": "2020-08-06", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02845752" }, { "nct_id": "NCT03265145", "title": "Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Stiolto Respimat", "type": "DRUG" }, { "name": "ICS (Inhaled Corticosteroid) (Triple therapy)", "type": "DRUG" }, { "name": "LABA (Long-Acting Beta Agonist) (Triple therapy)", "type": "DRUG" }, { "name": "LAMA (Long-Acting Muscarinic Antagonist) (Triple therapy)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 714, "start_date": "2017-09-20", "completion_date": "2020-09-30", "has_results": true, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 90, "location_summary": "Mobile, Alabama • Montgomery, Alabama • Tucson, Arizona + 84 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Apple Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03265145" }, { "nct_id": "NCT03240575", "title": "The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Tiotropium", "type": "DRUG" }, { "name": "Olodaterol", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 302, "start_date": "2017-08-14", "completion_date": "2019-05-06", "has_results": true, "last_update_posted_date": "2020-04-16", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 45, "location_summary": "Jasper, Alabama • Flagstaff, Arizona • Fullerton, California + 40 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Flagstaff", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03240575" }, { "nct_id": "NCT01431287", "title": "Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "tiotropium + olodaterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "olodaterol", "type": "DRUG" }, { "name": "Respimat", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2539, "start_date": "2011-09", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-07-16", "last_synced_at": "2026-10-01T12:06:01.406Z", "location_count": 38, "location_summary": "Greer, California • Fort Collins, Colorado • Danbury, Connecticut + 32 more", "locations": [ { "city": "Greer", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Danbury", "state": "Connecticut" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01431287" } ] }